Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
  • Overview
  • Insights
  • Recognition

About Janis

Janis K. Fraser, Ph.D., is a scientist-turned-lawyer who specializes in finding practical solutions to the most challenging patent issues that frequently accompany complex biotechnology and pharmaceutical inventions. A principal in the Boston office of Fish & Richardson P.C., Dr. Fraser has been providing strategic patent advice for over 25 years to clients ranging from startup biotech companies to multinational pharmaceutical corporations to academic institutions. She has assisted clients in obtaining patents claiming inventions such as antibodies, gene therapies, recombinant proteins, transgenic animals, pharmaceutical compounds and formulations, cosmetics, methods of treatment, and diagnostic methods. Dr. Fraser has a particular interest in patent issues surrounding personalized medicine. Her expertise extends to due diligence studies and opinions regarding validity and infringement issues.

Dr. Fraser is consistently recognized as a “Life Science Star” by LMG Life Sciences (2012-2022), where clients are quoted as describing her as “creative, open minded, attentive to detail,” an “expert at managing difficult prosecution and opinion related issues,” and someone who possesses a “strong work ethic, and encyclopedic understanding of every facet of U.S. patent law” and is “always in possession of a creative solution.” Recently, that publication cites clients who point to her “deep experience as a counselor to biotechnology and pharmaceutical companies” and say, “Janis is a trusted advisor in patent prosecution strategy and opinion drafting. She has a depth of knowledge that is unmatched in the field of biologics patent law.”

Publications

  • “Patent-eligible Subject Matter in the Life Sciences in the United States,” Japanese IP Journal, Vol. 16 No. 1: 20-30 (2019)
  • An End-Run Around Myriad And ‘Product Of Nature’ Problem,” Law360 (September 2016)
  • Co-creator and lecturer for Patent Resources Group Advanced Patent Law Course, “Pharma & Biotech Patents: A Hatch-Waxman and BPCIA (Biosimilars) Immersion Course Encompassing Prosecution Strategies, FDA Regulation, Post-Grant Challenge, and Litigation” (2015-2019)
  • Bulletproofing Pharma Patents,” LSIPR Newsletter (December 2014)
  • Co-creator and lecturer for Patent Resources Group Advanced Patent Law Course, “Pharma & Biotech Strategies for Patent Prosecution, Hatch-Waxman, and Litigation” (2000-2014)
  • “Patenting Genes in a Post-Myriad World,” Industrial Biotechnology (August 2013)
  • Myriad: Picking Up the Pieces,” LSIPR Newsletter (June 2013).
  • Making Follow-On Biologics a Reality,” Genetic Engineering & Biotechnology News 31:8-10 (2011)
  • U.S. Gene Patents in Legal Limbo—for Now,” Genetic Engineering & Biotechnology News 28:10 (2008)
  • In Vitro HeLa DNA Synthesis: Investigation of the Nature of Replication and a Stimulatory Factor from HeLa Cells,” Ph.D. Thesis
  • “The Best Lawyers in America” list in Patent Law, The Best Lawyers in America© (2022-2023)
  • “The World’s Leading Patent Practitioners,” IAM Patent 1000 (2016-2022)
  • “IP Star,” Managing Intellectual Property magazine (2014-2022)
  • “Life Science Star,” LMG Life Sciences (2012-2022)
  • “Top 250 Women in IP,” Managing Intellectual Property magazine (2019)
  • “Global Award—Life Sciences Law USA,” Lawyer International (2019)
  • “Best Lawyers in New England,” The Wall Street Journal (2018)
  • “World’s Leading Life Sciences Lawyer,” Who’s Who Legal (2016)
Focus Areas
Education

J.D., Harvard Law School (1985)


Ph.D., Biochemistry, Massachusetts Institute of Technology (1976)


B.S. with highest distinction, Chemistry, Nebraska Wesleyan University (1971)

Admissions
  • U.S. Patent and Trademark Office 1991
  • Massachusetts 1985
Memberships & Affiliations

​Member of the Editorial Board for Life Sciences Intellectual Property Review.

Member of the Advisory Board for MIT's David H. Koch Institute for Integrative Cancer Research.

What's trending with Janis

Filter by
News
September 29, 2022
LMG Life Sciences Awards Top Rankings to Fish & Richardson; 16 Principals Named 2022 “Life Sciences Stars”
Press Release
Announcements
News
News
September 8, 2022
Fish & Richardson Receives Top Rankings in 2022 Edition of IAM Patent 1000: The World’s Leading Patent Professionals
Press Release
Recognition
News
News
August 22, 2022
96 Fish Attorneys Included in the 2023 Edition of The Best Lawyers in America
Press Release
Announcements
Recognition
News
News
June 2, 2022
Fish & Richardson Named a Top ITC and Life Sciences Firm by Managing IP; Attorneys Named IP Stars
Press Release
Announcements
Recognition
News
News
October 5, 2021
LMG Life Sciences Awards Top Rankings to Fish & Richardson; 13 Principals Named 2021 “Life Sciences Stars”
Press Release
News
News
August 19, 2021
Fish Attorneys Recognized in 2022 edition of The Best Lawyers in America
Recognition
News
News
July 7, 2021
Fish & Richardson Receives Top Rankings in 2021 Edition of IAM Patent 1000: The World’s Leading Patent Professionals
Recognition
News
News
September 29, 2020
Fish & Richardson Receives Top Firm Rankings and 14 Principals Named 2020 “Life Sciences Stars” by LMG Life Sciences
Press Release
Recognition
News
News
August 12, 2020
Fish & Richardson Receives Top “Gold” Ranking from IAM Patent 1000 for National Litigation Practice; National Rankings in the Plaintiff Firm and Prosecution Firm Categories
Press Release
Recognition
News
News
August 4, 2020
32 Fish & Richardson Attorneys Named 2020 “IP Stars” by Managing Intellectual Property Magazine
Recognition
News
News
October 2, 2019
Fish & Richardson Receives Top Firm Rankings from LMG Life Sciences in Four Practice Areas
Press Release
Recognition
News
News
May 22, 2019
Fish & Richardson Announces 32 Attorneys Named “IP Stars” by Managing Intellectual Property Magazine
Press Release
Recognition
News
load more topics
TOP